Furthermore, we analyzed the overall survival (OS) and disease specific survival (DSS) data of cervical cancer, and found that the overall survival prognosis of patients with low expression of TRPV1 showed worse prognosis, while patients with high expression of TRPM1 showed worse prognosis (Figures 2A,B). Here, TRPV1 is linked to cervical cancer.